




































































Many healthcare companies are working on digital tools that can improve patient enrollment, patient data collection and the design of trials. Has digital enabled decentralized trials at scale? Do digital biomarkers represent an opportunity to effectively capture primary endpoints in a clinical trial? In this stream we will delve into the challenges of decentralized trials and the potential of digital biomarkers in clinical trials. Join the catalysts of this industry to explore the current climate, and the future of innovation in trials.